Healthcare Market Research Reports & Industry Analysis

Publications found: 73,128

Sort by:

Prediabetes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major prediabetes markets reached a value of US$ 23.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 48.7 Billion by 2034, exhibiting a growth rate (CAGR) of 6.72% du...

May 2024 130 pages

Preeclampsia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major preeclampsia markets reached a value of US$ 712.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 856.5 Million by 2034, exhibiting a growth rate (CAGR) of 1.69%...

May 2024 133 pages

Premature Ejaculation Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major premature ejaculation markets reached a value of US$ 2.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.3 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 134 pages

Presbyopia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major presbyopia markets are expected to exhibit a CAGR of 3.29% during 2024-2034. The presbyopia market has been comprehensively analyzed in IMARC's new report titled 'Presbyopia Market: Epidem...

May 2024 130 pages

Primary Biliary Cholangitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major primary biliary cholangitis markets reached a value of US$ 510 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,200 Million by 2034, exhibiting a growth rate (C...

May 2024 136 pages

Primary Gastric Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major primary gastric lymphoma markets reached a value of US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8.1 Billion by 2034, exhibiting a growth rate (CAGR)...

May 2024 134 pages

Primary Immune Deficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major primary immune deficiency markets reached a value of US$ 5.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 9.4 Billion by 2034, exhibiting a growth rate (CAGR)...

May 2024 135 pages

Primary Myelofibrosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major primary myelofibrosis markets are expected to exhibit a CAGR of 3.07% during 2024-2034. The primary myelofibrosis market has been comprehensively analyzed in IMARC's new report titled 'Pri...

May 2024 140 pages

Primary Sclerosing Cholangitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major primary sclerosing cholangitis markets are expected to exhibit a CAGR of 5.84% during 2024-2034. The primary sclerosing cholangitis market has been comprehensively analyzed in IMARC's new...

May 2024 137 pages

Prinzmetal Angina Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Prinzmetal angina markets are expected to exhibit a CAGR of 3.8% during 2024-2034. The Prinzmetal angina market has been comprehensively analyzed in IMARC's new report titled 'Prinzmetal A...

May 2024 133 pages

Progressive Familial Intrahepatic Cholestasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major progressive familial intrahepatic cholestasis markets are expected to exhibit a CAGR of 4.68% during 2024-2034. The progressive familial intrahepatic cholestasis market has been comprehens...

May 2024 140 pages

Progressive Pulmonary Fibrosis (PPF) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The progressive pulmonary fibrosis (PPF) market has been comprehensively analyzed in IMARC's new report titled 'Progressive Pulmonary Fibrosis (PPF) Market: Epidemiology, Industry Trends, Share, Size,...

May 2024 134 pages

Proliferative Vitreoretinopathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major proliferative vitreoretinopathy markets reached a value of US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.1 Billion by 2034, exhibiting a growth rate...

May 2024 139 pages

Propionic Acidemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major propionic acidemia markets are expected to exhibit a CAGR of 2.74% during 2024-2034. The propionic acidemia market has been comprehensively analyzed in IMARC's new report titled 'Propionic...

May 2024 137 pages

Proteinuria Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major proteinuria markets reached a value of US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.7 Billion by 2034, exhibiting a growth rate (CAGR) of 6.14% duri...

May 2024 129 pages

Proteus Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The proteus syndrome market reached a value of US$ 1.2 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1.8 Billion by 2034,...

May 2024 132 pages

Prurigo Nodularis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major prurigo nodularis markets are expected to exhibit a CAGR of 3.07% during 2024-2034. The prurigo nodularis market has been comprehensively analyzed in IMARC's new report titled 'Prurigo Nod...

May 2024 140 pages

Pruritus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major pruritus markets reached a value of US$ 6.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.8 Billion by 2034, exhibiting a growth rate (CAGR) of 2.42% during...

May 2024 137 pages

Pseudoxanthoma Elasticum Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major pseudoxanthoma elasticum markets are expected to exhibit a CAGR of 1.21% during 2024-2034. The pseudoxanthoma elasticum market has been comprehensively analyzed in IMARC's new report title...

May 2024 135 pages

Psoriasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The psoriasis market reached a value of US$ 19.2 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$ 35.8 Billion by...

May 2024 133 pages

Psychomotor Agitation Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major psychomotor agitation markets are expected to exhibit a CAGR of 1.92% during 2024-2034. The psychomotor agitation market has been comprehensively analyzed in IMARC's new report titled 'Psy...

May 2024 136 pages

Psychosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major psychosis markets reached a value of US$ 10.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 16.5 Billion by 2034, exhibiting a growth rate (CAGR) of 4.68% duri...

May 2024 138 pages

Ptosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ptosis markets reached a value of US$ 770.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,306.2 Million by 2034, exhibiting a growth rate (CAGR) of 4.92% dur...

May 2024 136 pages

Pulmonary Embolism Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major pulmonary embolism markets reached a value of US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.3 Billion by 2034, exhibiting a growth rate (CAGR) of 5.5...

May 2024 136 pages

Pulmonary Hypertension Associated with Interstitial Lung Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major pulmonary hypertension associated with interstitial lung disease markets reached a value of US$ 1.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1.6 Billion b...

May 2024 134 pages

Pulmonary Sarcoidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major pulmonary sarcoidosis markets reached a value of US$ 17.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 53.3 Billion by 2034, exhibiting a growth rate (CAGR) o...

May 2024 128 pages

Pyoderma Gangrenosum Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major pyoderma gangrenosum markets reached a value of US$ 126.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 185.1 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 131 pages

Pyruvate Kinase Deficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major pyruvate kinase deficiency markets are expected to exhibit a CAGR of 3.99% during 2024-2034. The pyruvate kinase deficiency market has been comprehensively analyzed in IMARC's new report t...

May 2024 138 pages

Raynaud's Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Raynaud's disease markets are expected to exhibit a CAGR of 7.68% during 2024-2034. The Raynaud's disease market has been comprehensively analyzed in IMARC's new report titled 'Raynaud's D...

May 2024 131 pages

Recurrent Glioblastoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major recurrent glioblastoma markets are expected to exhibit a CAGR of 5.85% during 2024-2034. The recurrent glioblastoma market has been comprehensively analyzed in IMARC's new report titled 'R...

May 2024 130 pages

Recurrent Head and Neck Squamous Cell Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major recurrent head and neck squamous cell carcinoma markets reached a value of US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.5 Billion by 2034, exhibitin...

May 2024 128 pages

Recurrent Malignant Glioma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major recurrent malignant glioma markets reached a value of US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.2 Billion by 2034, exhibiting a growth rate (CAGR...

May 2024 130 pages

Recurrent Pericarditis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major recurrent pericarditis markets are expected to exhibit a CAGR of 4.08% during 2024-2034. The recurrent pericarditis market has been comprehensively analyzed in IMARC's new report titled 'R...

May 2024 134 pages

Relapsed Refractory Multiple Myeloma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major relapsed refractory multiple myeloma markets reached a value of US$ 21.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 34.4 Billion by 2034, exhibiting a growt...

May 2024 128 pages

Renal Cell Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major renal cell carcinoma markets reached a value of US$ 4.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.3 Billion by 2034, exhibiting a growth rate (CAGR) of 4...

May 2024 134 pages

Renal Insufficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major renal insufficiency markets reached a value of US$ 9.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 22.7 Billion by 2034, exhibiting a growth rate (CAGR) of 8...

May 2024 137 pages

Respiratory Distress Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major respiratory distress syndrome markets are expected to exhibit a CAGR of 4.56% during 2024-2034. The respiratory distress syndrome market has been comprehensively analyzed in IMARC's new re...

May 2024 133 pages

Respiratory Syncytial Virus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major respiratory syncytial virus markets reached a value of US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.8 Billion by 2034, exhibiting a growth rate (CAG...

May 2024 134 pages

Restless Legs Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major restless legs syndrome markets are expected to exhibit a CAGR of 2.49% during 2024-2034. The restless legs syndrome market has been comprehensively analyzed in IMARC's new report titled 'R...

May 2024 130 pages

Retinal Edema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major retinal edema markets reached a value of US$ 5.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 13.5 Billion by 2034, exhibiting a growth rate (CAGR) of 7.84% d...

May 2024 135 pages

Retinitis Pigmentosa Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major retinitis pigmentosa markets reached a value of US$ 9.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 17.1 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 133 pages

Retinopathy of Prematurity Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major retinopathy of prematurity markets are expected to exhibit a CAGR of 5.1% during 2024-2034. The retinopathy of prematurity market has been comprehensively analyzed in IMARC's new report ti...

May 2024 139 pages

Rett Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Rett syndrome markets reached a value of US$ 182.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 419.4 Million by 2034, exhibiting a growth rate (CAGR) of 7.85...

May 2024 131 pages

Rheumatic Diseases Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major rheumatic diseases markets reached a value of US$ 24.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 29.0 Billion by 2034, exhibiting a growth rate (CAGR) of 1...

May 2024 128 pages

Rheumatoid Arthritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major rheumatoid arthritis markets reached a value of US$ 27.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 33.8 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 133 pages

Rhinosinusitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major rhinosinusitis markets reached a value of US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.0 Billion by 2034, exhibiting a growth rate (CAGR) of 4.64% d...

May 2024 129 pages

Richter's Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The Richter's syndrome market size in top seven countries reached US$ 448.8 Million in 2023. Looking forward, IMARC Group expects the market in top seven countries to reach US$ 713.2 Million by 2034,...

May 2024 131 pages

Ringworm Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ringworm markets are expected to exhibit a CAGR of 3.49% during 2024-2034. The ringworm market has been comprehensively analyzed in IMARC's new report titled 'Ringworm Market: Epidemiology...

May 2024 133 pages

Rosai-Dorfman Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Rosai-Dorfman disease markets reached a value of US$ 318.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 568.9 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 131 pages

Rotavirus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major rotavirus markets are expected to exhibit a CAGR of 8.62% during 2024-2034. The rotavirus market has been comprehensively analyzed in IMARC's new report titled 'Rotavirus Market: Epidemiol...

May 2024 131 pages

Filters

Clear all

Price

—

Date

—

Pages

—

Offers

33% OFF on “TCR-Based Antibody a...

Discount Offer from GMD Research

280

Special Offer from MP Advisors

Special Offer on Therapy Class R...